SEER is an authoritative source of information on cancer incidence and survival in the United States. SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 28 percent of the U.S. population.
Code grade specified by pathologist. If no grade specified, code 9
This is an AML that may present de novo or arise from a prior MDS. It is often associated with normal or elevated peripheral bloodplatelet counts and has increased atypical bone marrow megakaryocytes with mono- or bi-lobated nuclei and associated multilineage dysplasia.
(This code is effective for cases diagnosed 2010 and later. For cases diagnosed prior to 2010 see code 9861/3.)
Patients may have a prior MDS or present with splenomegaly.